160 related articles for article (PubMed ID: 25948597)
21. Siblings of patients with rheumatoid arthritis have an increased mortality rate: a Swedish cohort study.
Westerlind H; Delcoigne B; Askling J
RMD Open; 2020 May; 6(1):. PubMed ID: 32423969
[TBL] [Abstract][Full Text] [Related]
22. Are patients with rheumatoid arthritis still at an increased risk of tuberculosis and what is the role of biological treatments?
Arkema EV; Jonsson J; Baecklund E; Bruchfeld J; Feltelius N; Askling J;
Ann Rheum Dis; 2015 Jun; 74(6):1212-7. PubMed ID: 24608401
[TBL] [Abstract][Full Text] [Related]
23. Population-based mortality outcome of rheumatoid arthritis in females.
Iacovino JR
J Insur Med; 2002; 34(2):86-8. PubMed ID: 15305782
[TBL] [Abstract][Full Text] [Related]
24. No increased occurrence of ischemic heart disease prior to the onset of rheumatoid arthritis: results from two Swedish population-based rheumatoid arthritis cohorts.
Holmqvist ME; Wedrén S; Jacobsson LT; Klareskog L; Nyberg F; Rantapää-Dahlqvist S; Alfredsson L; Askling J
Arthritis Rheum; 2009 Oct; 60(10):2861-9. PubMed ID: 19790058
[TBL] [Abstract][Full Text] [Related]
25. Impact of Rheumatoid Arthritis on the Mortality of Elderly Patients Who Develop Cancer: A Population-Based Study.
Nayak P; Luo R; Elting L; Zhao H; Suarez-Almazor ME
Arthritis Care Res (Hoboken); 2017 Jan; 69(1):75-83. PubMed ID: 27483088
[TBL] [Abstract][Full Text] [Related]
26. Cancer risk in patients with rheumatoid arthritis treated with anti-tumor necrosis factor alpha therapies: does the risk change with the time since start of treatment?
Askling J; van Vollenhoven RF; Granath F; Raaschou P; Fored CM; Baecklund E; Dackhammar C; Feltelius N; Cöster L; Geborek P; Jacobsson LT; Lindblad S; Rantapää-Dahlqvist S; Saxne T; Klareskog L
Arthritis Rheum; 2009 Nov; 60(11):3180-9. PubMed ID: 19877027
[TBL] [Abstract][Full Text] [Related]
27. Costs for hospital care, drugs and lost work days in incident and prevalent rheumatoid arthritis: how large, and how are they distributed?
Eriksson JK; Johansson K; Askling J; Neovius M
Ann Rheum Dis; 2015 Apr; 74(4):648-54. PubMed ID: 24323395
[TBL] [Abstract][Full Text] [Related]
28. Mortality rates in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors: drug-specific comparisons in the Swedish Biologics Register.
Simard JF; Neovius M; Askling J;
Arthritis Rheum; 2012 Nov; 64(11):3502-10. PubMed ID: 22886739
[TBL] [Abstract][Full Text] [Related]
29. Increased risk of chronic obstructive pulmonary disease in patients with rheumatoid arthritis: a population-based cohort study.
Shen TC; Lin CL; Chen CH; Tu CY; Hsia TC; Shih CM; Hsu WH; Sung FC
QJM; 2014 Jul; 107(7):537-43. PubMed ID: 24497528
[TBL] [Abstract][Full Text] [Related]
30. The risk of asthma in rheumatoid arthritis: a population-based cohort study.
Shen TC; Lin CL; Wei CC; Tu CY; Li YF
QJM; 2014 Jun; 107(6):435-42. PubMed ID: 24448376
[TBL] [Abstract][Full Text] [Related]
31. Rheumatoid arthritis, anti-tumour necrosis factor therapy, and risk of malignant melanoma: nationwide population based prospective cohort study from Sweden.
Raaschou P; Simard JF; Holmqvist M; Askling J;
BMJ; 2013 Apr; 346():f1939. PubMed ID: 23568792
[TBL] [Abstract][Full Text] [Related]
32. Statin use and mortality in rheumatoid arthritis: a general population-based cohort study.
Schoenfeld SR; Lu L; Rai SK; Seeger JD; Zhang Y; Choi HK
Ann Rheum Dis; 2016 Jul; 75(7):1315-20. PubMed ID: 26245753
[TBL] [Abstract][Full Text] [Related]
33. Cancer in rheumatoid arthritis: occurrence, mortality, and associated factors in a South European population.
Abásolo L; Júdez E; Descalzo MA; González-Alvaro I; Jover JA; Carmona L;
Semin Arthritis Rheum; 2008 Jun; 37(6):388-97. PubMed ID: 17977580
[TBL] [Abstract][Full Text] [Related]
34. Rheumatoid Arthritis and Risk of Malignant Lymphoma: Is the Risk Still Increased?
Hellgren K; Baecklund E; Backlin C; Sundstrom C; Smedby KE; Askling J
Arthritis Rheumatol; 2017 Apr; 69(4):700-708. PubMed ID: 27992692
[TBL] [Abstract][Full Text] [Related]
35. No increased risk of malignancies and mortality in cyclosporin A-treated patients with rheumatoid arthritis.
van den Borne BE; Landewé RB; Houkes I; Schild F; van der Heyden PC; Hazes JM; Vandenbroucke JP; Zwinderman AH; Goei The HS; Breedveld FC; Bernelot Moens HJ; Kluin PM; Dijkmans BA
Arthritis Rheum; 1998 Nov; 41(11):1930-7. PubMed ID: 9811046
[TBL] [Abstract][Full Text] [Related]
36. Survival rates of cancer patients with and without rheumatic disease: a retrospective cohort analysis.
Park JK; Yang JA; Ahn EY; Chang SH; Song YW; Curtis JR; Lee EB
BMC Cancer; 2016 Jul; 16():381. PubMed ID: 27412038
[TBL] [Abstract][Full Text] [Related]
37. Occurrence of extraarticular disease manifestations is associated with excess mortality in a community based cohort of patients with rheumatoid arthritis.
Turesson C; O'Fallon WM; Crowson CS; Gabriel SE; Matteson EL
J Rheumatol; 2002 Jan; 29(1):62-7. PubMed ID: 11824973
[TBL] [Abstract][Full Text] [Related]
38. Increased case fatality rates following a first acute cardiovascular event in patients with rheumatoid arthritis.
Van Doornum S; Brand C; King B; Sundararajan V
Arthritis Rheum; 2006 Jul; 54(7):2061-8. PubMed ID: 16802340
[TBL] [Abstract][Full Text] [Related]
39. Educational inequalities in mortality associated with rheumatoid arthritis and other musculoskeletal disorders in Sweden.
Kiadaliri AA; Petersson IF; Englund M
BMC Musculoskelet Disord; 2019 Feb; 20(1):83. PubMed ID: 30777043
[TBL] [Abstract][Full Text] [Related]
40. Trends in all-cause and cardiovascular mortality in patients with incident rheumatoid arthritis: a 20-year follow-up matched case-cohort study.
Provan SA; Lillegraven S; Sexton J; Angel K; Austad C; Haavardsholm EA; Kvien TK; Uhlig T
Rheumatology (Oxford); 2020 Mar; 59(3):505-512. PubMed ID: 31504942
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
